Ovid Therapeutics Inc. (OVID) SEC Filings — 2025
16 SEC filings for Ovid Therapeutics Inc. (OVID) in 2025.
Filings
- Ovid Therapeutics Inc. 8-K Filing — 8-K · Dec 18, 2025
- Ovid Therapeutics Inc. 8-K Filing — 8-K · Dec 11, 2025
- Ovid's Q3 Loss Narrows, Cash Infusion Boosts Outlook — 10-Q · Nov 12, 2025
- Ovid Seeks 152% Stock Authorization Hike for PIPE Financing — DEF 14A · Nov 7, 2025
- Ovid Therapeutics Files 8-K on Agreements and Equity Sales — 8-K · Oct 3, 2025
- Ovid Therapeutics Files 8-K Current Report — 8-K · Sep 16, 2025
- Ovid Therapeutics Faces Going Concern Doubt Amidst Widening Losses — 10-Q · Aug 13, 2025
- Ovid Therapeutics Files 8-K on Security Holder Matters — 8-K · Jul 10, 2025
- Ovid Therapeutics Files 8-K — 8-K · Jun 25, 2025
- Ovid Therapeutics Details 2024 Executive Equity Compensation — DEF 14A · May 22, 2025
- Ovid Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Ovid Therapeutics Files 8-K on Shareholder Nominations — 8-K · May 2, 2025
- Ovid Therapeutics Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
- Ovid Therapeutics Inc. 10-K Filing — 10-K · Mar 11, 2025
- Ovid Therapeutics Announces Executive and Director Appointments — 8-K · Mar 5, 2025
- Ovid Therapeutics Faces Delisting Concerns — 8-K · Feb 13, 2025